top of page

Success Stories

Investor-Grade Legal Due Diligence for a MedTech Deal

Pink Oyster Mushrooms

Related Posts

Subscribe to The Source

Sign up now to receive periodical Alfred updates, resources and insights, direct to your mailbox

cta.jpeg

Ready to take your vision to the next level?

Email us at info@alfred.ch or schedule a free introductory call to discuss how we can support you.

The Situation

An investor was eyeing a promising MedTech startup for a major investment. The tech looked solid, the market potential was there—but before writing a check, they needed a deep dive into the legal landscape.


Our Approach

A top-tier legal due diligence report isn’t just a checkbox—it’s a sanity check for both sides. Investors get clarity on:


  •  🔏 IP – Does the startup actually own its core technology?

  •  📜 Contracts – Any hidden liabilities in supplier, customer, or partnership agreements?

  •  🛖 Corporate Structure – Clean incorporation, shareholder percentages and rights, and governance?

  •  🥨 Regulatory Compliance – Are FDA/CE approvals and industry compliance in place?

  •  🍰 HR & Incentives – Employment contracts, ESOPs, and potential disputes?

  •  👩‍⚖️ Claims & Litigation – Any red flags that could derail the deal?


The Impact

Alfred produced a clear, risk-mapped due diligence report that helped the investors negotiate smarter while also giving the founders peace of mind—fully disclosed facts mean no future liability surprises.


"Alfred gave us the confidence to move forward. Their sharp legal DD uncovered key points that shaped our deal terms and built a strong foundation for collaboration." - Investor

The Team


Thomas van Gammeren, Associate (Legal Advisory)
Thomas van Gammeren, Associate (Legal Advisory)
Tatjana Jendritzky, Senior Counsel (Legal Advisory)
Tatjana Jendritzky, Senior Counsel (Legal Advisory)
Sandro Stich, Senior Associate (Legal Advisory)
Sandro Stich, Senior Associate (Legal Advisory)











Opmerkingen


Opmerkingen zijn uitgezet.
bottom of page